296 related articles for article (PubMed ID: 7209360)
1. Additional antitumoral effects of bromocriptine and radiotherapy in patients with prolactinomas or acromegaly.
Coculescu M; Alessandrescu D; Stoica T; Simionescu N; Dimitriu V; Oprescu M; Chelmu S; Urba-Navicius V; Isbăşoiu O
Endocrinologie; 1980; 18(4):277-88. PubMed ID: 7209360
[TBL] [Abstract][Full Text] [Related]
2. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
[TBL] [Abstract][Full Text] [Related]
3. The hormonal effects of pituitary surgery and irradiation: a review of 59 cases.
Wittert G; Donald RA; Espiner EA; Livesey JH; Fox H
N Z Med J; 1985 Feb; 98(773):93-7. PubMed ID: 2983273
[TBL] [Abstract][Full Text] [Related]
4. [Follow-up of patients with pituitary tumors before and after operation, medical treatment and radiotherapy (author's transl)].
Gasser RW; Finkenstedt G; Skrabal F
Acta Med Austriaca; 1981; 8(4):112-20. PubMed ID: 7315152
[TBL] [Abstract][Full Text] [Related]
5. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
[TBL] [Abstract][Full Text] [Related]
6. Lack of effect of hyperprolactinemia on glucose disposal and insulin secretion in patients with prolactinomas.
Katz EJ; Donald RA; Beaven DW; Espiner EA
Horm Metab Res; 1981 Dec; 13(12):667-9. PubMed ID: 7033092
[TBL] [Abstract][Full Text] [Related]
7. Giant invasive prolactinoma: a case report and review of nine further cases.
Davis JR; Sheppard MC; Heath DA
Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731
[TBL] [Abstract][Full Text] [Related]
8. Prolactin secreting adenoma in 22 men.
Grisoli F; Vincentelli F; Jaquet P; Guibout M; Hassoun J; Farnarier P
Surg Neurol; 1980 Apr; 13(4):241-7. PubMed ID: 7376059
[TBL] [Abstract][Full Text] [Related]
9. Prolactin and placental hormone levels during pregnancy in prolactinomas.
Batrinos ML; Panitsa-Faflia C; Anapliotou M; Pitoulis S
Int J Fertil; 1981; 26(2):77-85. PubMed ID: 6114069
[TBL] [Abstract][Full Text] [Related]
10. [Drug and radiotherapy of pituitary tumors].
Yoshida H; Takeda F; Kinouchi T; Shimizu N
Nihon Rinsho; 1986 Mar; 44(3):659-66. PubMed ID: 3016373
[No Abstract] [Full Text] [Related]
11. The treatment of acromegaly.
Lamberts SW; Klijn JG; De Lange SA; Birkenhäger JC
Neth J Med; 1979; 22(5):161-6. PubMed ID: 388245
[No Abstract] [Full Text] [Related]
12. Hypothalamic-pituitary function following bromocriptine therapy in patients with prolactinomas.
Badawy SZ; Notman DD; Sunderlin FS; Springer JM; Streeten DH; Omar MM; Marshall LD
J Reprod Med; 1982 Mar; 27(3):139-45. PubMed ID: 6806469
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
Nillius SJ
Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
[TBL] [Abstract][Full Text] [Related]
14. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
Lloyd HM; Jacobi JM; Willgoss DA
Clin Endocrinol (Oxf); 1995 Jul; 43(1):79-85. PubMed ID: 7641414
[TBL] [Abstract][Full Text] [Related]
15. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine in the medical management of acromegaly.
Besser GM; Wass JA; Thorner MO
Adv Biochem Psychopharmacol; 1980; 23():191-8. PubMed ID: 6249090
[No Abstract] [Full Text] [Related]
17. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
Glaser B; Nesher Y; Barziliai S
J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
[TBL] [Abstract][Full Text] [Related]
19. Hormonal evidence for the dissemination through the cerebrospinal fluid, of secreting cells from invasive pituitary adenomas.
Coculescu M; Temel E; Oprescu M; Constantinovici A; Carp N; Simiónescu N
Endocrinologie; 1981; 19(2):129-35. PubMed ID: 7256167
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
